ABSTRACT
This was a cross-sectional community-based serological survey of polio antibodies assessing the immunogenicity of inactivated poliovirus vaccine (IPV) focusing on poliovirus serotype 2. IPV was administered to 5-month-old children. Type 2 antibody seroprevalence when measured 1 month after IPV administration was >95%. One IPV dose successfully closed the immunity gap.
Subject(s)
Poliomyelitis , Poliovirus , Antibodies, Viral , Child , Cross-Sectional Studies , Humans , Immunization Schedule , Infant , Poliomyelitis/prevention & control , Poliovirus Vaccine, Inactivated , Seroepidemiologic Studies , Vietnam/epidemiologyABSTRACT
While the contribution of industrial parks to the socio-economic aspect has been widely acknowledged over the past two decades in Vietnam, the problem of environmental pollution due to the wastes generated from industrial parks, especially wastewater, has still been an emerging issue, which places a great pressure on the Government. The wastewater generation from industrial parks was ordinarily required to report in all environmental impact assessment (EIA) reports as a base for the construction of on-site wastewater treatment plants within the industrial park. In Vietnam, this data was, however, often higher than the actual generated number due to inaccurate technical guidelines on predicting wastewater generation and many different methods to be applied. This study aimed to evaluate different approaches used to calculate the effluent in the industrial parks. The results showed that all of the four approaches (i.e., previous operation-based, water-based, wastewater-based, or experience-based methods) rendered significant gaps between predicted and actual values. None can be acceptable for use at present. A revision of technical guideline should be conducted to provide more detailed instruction for the better prediction. This shall minimize the investment capital and increase the efficiency of industrial parks in pollution control.
Subject(s)
Environmental Monitoring , Industrial Waste , Wastewater/statistics & numerical data , Industry , VietnamABSTRACT
In recent years, serosurveillance has gained momentum as a way of determining disease transmission and immunity in populations, particularly with respect to vaccine-preventable diseases. At the end of 2017, the Oxford University Clinical Research Unit and the National Institute of Hygiene and Epidemiology held a meeting in Vietnam with national policy makers, researchers, and international experts to discuss current seroepidemiologic projects in Vietnam and future needs and plans for nationwide serosurveillance. This report summarizes the meeting and the plans that were discussed to set up nationwide serosurveillance in Vietnam.
Subject(s)
Population Surveillance/methods , Seroepidemiologic Studies , Humans , Vietnam/epidemiologyABSTRACT
Measles-associated deaths have been reported in infants <9â¯months during outbreaks. A cohort study was conducted on 210 infants aged 6-8â¯months to evaluate the immunogenicity and safety of the AIK-C measles vaccine containing 104.21 plaque-forming units (PFU)/0.5â¯mL produced in Vietnam. Paired serum samples were obtained from 196 subjects. Seropositivity was defined as ≥120 mIU/mL. The seroresponse rate was 173/196 (88.27%, 95% confidence interval (CI): 83.77-92.77%) with geometric mean titer (GMT) of 511 mIU/mL (95% CI: 688-880 mIU/mL), and no significant differences were observed by different age groups. Among 196 paired sera, they were categorized into four groups: 122 subjects <14â¯IU/mL, 28 subjects 14-<60 mIU/mL, 30 subjects 60-<120 mIU/mL, and 16 subjectsâ¯≥â¯120 mIU/mL. The seroresponse rate was 112/122 (91.8%, 95% CI: 86.94-96.67%) with GMT (597 mIU/mL, 95% CI: 749-1002 mIU/mL) in the <14 mIU/L group. In the 14-<60 mIU/mL group, the seroresponse rate was 18/28 (64.29%) with 184 mIU/L of GMT and was significantly lower (pâ¯<â¯0.01) than that in the <14 mIU/mL group. In the 16 seropositive group, all subjects showed seroconversion (4-fold higher than before) with a higher GMT of 1078 mIU/mL. Local pain and itching at the injection site were observed in 8 subjects (3.8%) within 7â¯days of the vaccination. Regarding systemic adverse reactions, febrile illness ≥37.5⯰C was observed in 14 subjects (6.7%). These results indicate that the AIK-C measles vaccine is effective and safe for infants aged 6-8â¯months and will contribute to reducing the number of measles-associated deaths in future outbreaks.
Subject(s)
Antibodies, Viral/immunology , Immunogenicity, Vaccine/immunology , Measles Vaccine/immunology , Cohort Studies , Female , Humans , Infant , Male , Measles/immunology , Measles/prevention & control , Measles virus/immunology , Seroconversion/physiology , Vaccination/methods , VietnamABSTRACT
BACKGROUND: Due to global shortage of inactivated poliovirus vaccine and withdrawal of oral vaccine containing poliovirus type 2 (PV2), a PV2-containing vaccine was not used in Vietnam May 2016 to October 2018. We assessed the population immunity gap to PV2. METHODS: A cross-sectional survey in children aged 1-18 months was carried out in January 2018. One blood sample per child was analyzed for presence of poliovirus neutralizing antibodies. In children with detectable anti-PV2 antibodies, a second sample was analyzed 4 months later to distinguish between passive (maternally derived) and active (induced by secondary transmission or vaccination) immunity. RESULTS: Sera were obtained from 1106/1110 children. Seroprevalence of PV2 antibodies was 87/368 (23.6%) at age 1-7 months, 27/471 (5.7%) at 8-15 months, and 19/267 (7.1%) at 16-18 months. Seroprevalence declined with age in the 1-7 months group; in the 8-18 months group there was no significant change with age. Four months later, 11/87 (14%), 9/27 (32%), and 12/19 (37%) remained seropositive in 1-7, 8-15, and 16-18 months age groups, respectively. CONCLUSIONS: We found declining immunity to PV2, suggesting Vietnam is at risk for an outbreak of type 2 vaccine-derived poliovirus following virus importation or new emergence.
Subject(s)
Poliovirus Vaccine, Inactivated/immunology , Poliovirus Vaccine, Oral/immunology , Poliovirus/immunology , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Child, Preschool , Cross-Sectional Studies , Disease Outbreaks/prevention & control , Female , Humans , Infant , Male , Poliomyelitis/immunology , Seroepidemiologic Studies , Vaccination/methods , VietnamABSTRACT
A prospective, multicentre study was conducted in four sentinel surveillance hospitals to assess the trend and epidemiology of acute diarrhea caused by Rotavirus in Vietnam. During the period 2012-2015, a total 8,889 children under 5â¯years of age were enrolled in the surveillance, and 8689 stool samples were collected. Of these cases, Rotavirus was most common pathogen 46.7% (4054 cases); in which 26.6% (1117) rotavirus-positive stool samples were evaluated to identify genotypes. The proportion of rotavirus positive specimens decreased annually from 54.7% in 2012 to 36.6% in 2015. Rotavirus was detected year-round, but most rotavirus gastroenteritis cases (77.1%) occurred between December and May, corresponding to the rotavirus seasonality. It is found that the peaks varied by regions. Rotavirus positivities varied between the youngest and oldest age, but children 6-11â¯months old (38.8%) and 12-23â¯months old (38.4%) counted for most cases. A significant higher number of diarrhea within 24â¯hours (8.3 times, 95%CI: 8.1-8.4 times) and higher proportion of severe dehydration (12.9%) in Rotavirus positive group than that in Rotavirus negative group (7.7 times, 95%CI: 7.6-7.9 times; and 9.7%, respectively). A downtrend of prevalence of G1P[8] was observed from 82% in 2013 to 15% in 2015. However, G2P[4] was found in 5% of samples in 2012, 9% in 2013, 36% in 2014, and 28% in 2015. Rotavirus infection is the most important cause of acute diarrhea among hospitalized children in Vietnam, and a rotavirus vaccination program for children may significantly reduce this disease.
Subject(s)
Diarrhea/epidemiology , Rotavirus Infections/epidemiology , Sentinel Surveillance , Acute Disease , Age Factors , Child, Preschool , Diarrhea/virology , Feces/virology , Female , Gastroenteritis/epidemiology , Gastroenteritis/virology , Genotype , Hospitalization/statistics & numerical data , Humans , Infant , Infant, Newborn , Male , Prevalence , Prospective Studies , Rotavirus/genetics , Rotavirus/isolation & purification , Seasons , Vietnam/epidemiologyABSTRACT
Supported by GAVI Alliance, measles-rubella vaccination was introduced in Vietnam in 2014, involving a mass campaign among 1-14 year olds and routine immunization of children aged 9 months. We explore the impact on the incidence of Congenital Rubella Syndrome (CRS) during 2013-2050 of this strategy and variants involving women aged 15-35 years. We use an age and sex-structured dynamic transmission model, set up using recently-collected seroprevalence data from Central Vietnam, and also consider different levels of transmission and contact patterns. If the serological profile resembles that in Central Vietnam, the planned vaccination strategy could potentially prevent 125,000 CRS cases by 2050 in Vietnam, despite outbreaks predicted in the meantime. Targeting the initial campaign at 15-35 year old women with or without children aged 9 months-14 years led to sustained reductions in incidence, unless levels of ongoing transmission were medium-high before vaccination started. Assumptions about contact greatly influenced predictions if the initial campaign just targeted 15-35 year old women and/or levels of ongoing transmission were medium-high. Given increased interest in rubella vaccination, resulting from GAVI Alliance funding, the findings are relevant for many countries.
Subject(s)
Rubella Vaccine/administration & dosage , Rubella Vaccine/immunology , Rubella/epidemiology , Rubella/prevention & control , Adolescent , Adult , Aged , Child , Child, Preschool , Disease Transmission, Infectious/prevention & control , Female , Humans , Immunization Programs , Incidence , Infant , Infant, Newborn , Middle Aged , Models, Statistical , Seroepidemiologic Studies , Vaccination , Vietnam/epidemiology , Young AdultABSTRACT
BACKGROUND: Introduction of human papillomavirus (HPV) vaccine in national programs has proceeded apace since 2006, mostly in high-income countries. Recently concluded pilots of HPV vaccination in low-income countries have provided important lessons learned for these settings; however, rigorous evaluations of the feasibility of these delivery strategies that effectively reach young adolescents have been few. This paper presents results from a qualitative evaluation of a demonstration program which implemented school-based and health center-based HPV vaccinations to all girls in grade 6, or 11 years of age, for two years in four districts of Vietnam. METHODS: Using semi-structured interviews of 131 health and education staff from local, district, province, and national levels and 26 focus-group discussions with local project implementers (n = 153), we conducted a qualitative two-year evaluation to measure the impact of HPV vaccinations on the health and education systems. RESULTS: HPV vaccine delivery at schools or health centers was made feasible by: a. close collaboration between the health and education sectors, b. detailed planning for implementation, c. clearly defined roles and responsibilities for project implementers, d. effective management and supervision of vaccinations during delivery, and e. engagement with community organizations for support. Both the health and education systems were temporarily challenged with the extra workload, but the disruptions were short-lived (a few days for each of three doses) and perceived as worth the longer-term benefit of cervical cancer prevention. CONCLUSION: The learning from Vietnam has identified critical elements for successful vaccine delivery that can provide a model for other countries to consider during their planning of national rollout of HPV vaccine.
Subject(s)
Immunization Programs/organization & administration , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , School Health Services , Attitude of Health Personnel , Child , Delivery of Health Care , Faculty , Feasibility Studies , Female , Focus Groups , Government Programs , Humans , Pregnancy , Qualitative Research , VietnamABSTRACT
BACKGROUND: The GAVI Alliance's decision in late 2011 to invite developing countries to apply for funding for human papillomavirus (HPV) vaccine introduction underscores the importance of understanding levels of HPV vaccine acceptance in developing country settings. In this paper, we present findings from qualitative research on parents' rationales for vaccinating or not vaccinating their daughters (vaccine acceptance) and their decision-making process in the context of an HPV vaccination demonstration project in Vietnam (2008-2009). METHODS: We designed a descriptive qualitative study of HPV vaccine acceptability among parents of girls eligible for vaccination in four districts of two provinces in Vietnama. The study was implemented after each of two years of vaccinations was completed. In total, 133 parents participated in 16 focus group discussions and 27 semi-structured interviews. RESULTS: Focus group discussions and in-depth interviews with parents of girls vaccinated revealed that they were generally very supportive of immunization for disease prevention and of vaccinating girls against HPV. The involvement of the National Expanded Program of Immunization in the demonstration project lent credibility to the HPV vaccine, contributing to high levels of acceptance. For parents who declined participation, concerns about side effects, the possibility that the vaccine was experimental, and the possible impact of the vaccine on future fertility rose to the surface. In terms of the decision-making process, many parents exhibited 'active decision-making,' reaching out to friends, family, and opinion leaders for guidance prior to making their decision. CONCLUSION: Vietnam's HPV vaccination experience speaks to the importance of close collaboration with the government to make the most of high levels of trust, and to reduce suspicions about new vaccines that may arise in the context of vaccine introduction in developing country settings.
Subject(s)
Decision Making , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , Parent-Child Relations , Parents/psychology , Patient Acceptance of Health Care/psychology , Vaccination/statistics & numerical data , Child , Female , Focus Groups , Humans , Qualitative Research , VietnamABSTRACT
BACKGROUND: Vietnam conducted a measles catch-up supplementary immunization activity (SIA) during 2002-2003 that targeted children 9 months-10 years of age, followed by subnational SIAs targeting persons up to 20 years of age during 2004 and 2007-2008. A measles epidemic began among young adults in October 2008 in the northern region, spread nationwide during early 2009, and continued during 2010. METHODS: We reviewed national epidemiologic and laboratory surveillance data. Measles cases were defined and classified according to World Health Organization recommendations. RESULTS: From October 2008 through January 2010, 7948 confirmed measles cases were reported from 60 of 63 provinces, an incidence of 93 cases per million population. Incidence was 328 cases per million population among children age 1-4 years, 318 cases per million population among infants, and 271 cases per million population among persons aged 20-24 years. Few cases were reported among persons 7-17 or >27 years of age. Median age of cases trended downward over time in all regions. CONCLUSIONS: The 2002-2003 measles SIA protected its targeted age group, but this epidemic was not prevented by follow-up subnational SIAs in selected provinces during 2007-2008. Transmission began among young adults and was sustained among children. The outcome of Vietnam's 2010 SIA targeting children only and change in routine schedule may influence elimination strategies for other countries.
Subject(s)
Epidemics , Measles Vaccine/administration & dosage , Measles/epidemiology , Adolescent , Adult , Age Distribution , Child , Child, Preschool , Demography , Female , Humans , Immunization Programs , Incidence , Infant , Male , Measles/prevention & control , Sex Distribution , Time Factors , Vietnam/epidemiology , Young AdultABSTRACT
BACKGROUND: Formative research is a useful tool for designing new health interventions. This paper presents key findings from formative research conducted in Vietnam to guide human papillomavirus (HPV) vaccine introduction. METHODS: We explored the sociocultural environment, health system capacity and the policy-making process using a combined quantitative and qualitative methodology. Data collection was done through literature review, in-depth interviews, focus group discussions, observation checklists and a structured questionnaire on knowledge, attitudes and practices. Populations of interest included 11- to 14-year-old girls, their parents, community leaders, teachers, health workers, health and education officials, and policy-makers at all levels. RESULTS: Although HPV vaccines are new, we found high potential acceptance among parents and girls. HPV vaccine introduction was also favourably supported by health professionals if assurances for system preparedness, e.g. cold chain and human resources, were made. There were no significant barriers from the policy perspective that would prevent the introduction of a new vaccine. However, several concerns related to this new vaccine would need to be adequately addressed before implementation. CONCLUSION: Our findings provide options for potential vaccine delivery strategies, appropriate communication strategies and targeted advocacy strategies to introduce HPV vaccines in the Vietnamese context.